ERBB2 and carcinoma: Carcinomas with a triple-negative phenotype (lack of HER2, and oestrogen and progesterone receptors; n=6) showed absence of hOGG1 expression, whereas 47 of 90 (52.2%) non-TNBCs showed hOGG1 expression (P=0.027).